E.g., 04/25/2024
E.g., 04/25/2024
Title Category Credit Event datesort descending Price
Life Long Learning Prep Course Webcast: Module 2: Calculi, Laparoscopy-Robotics and Upper Tract Obstruction (2021) $1,055.00 Specifically designed for anyone unable to get away from the office to attend the Live Course, the Webcast option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials.
Prostate Cancer Diagnosis: AUA Guidelines on Use of PSA Biomarkers, MRI and Biopsy Techniques Webcast (2023)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Prostate cancer detection remains one of the most common and most controversial aspects of urological practice. In addition to the complexities around screening and use of PSA, the role of other biomarkers, biopsy techniques such as transperineal biopsy and MRI for targeted biopsy are evolving rapidly. This course is intended for urologists, advanced practice providers and trainees interested in using the most evidence-based methods for optimizing detection of clinically important prostate cancers, while improving patient experience and minimizing complications.
PARPi: Management of Adverse Events Webcast (2024)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 The American Urological Association (AUA) has developed a series of live virtual and on-demand educational offerings to further address the identified educational gaps and barriers in advanced prostate cancer care. Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessments, a three-part educational series to update urologists and advanced practice providers (APPs) on PARP-inhibitor (PARPi) treatment in advanced prostate cancer is being offered.
Refractory Overactive Bladder: How to Select 3rd Line Therapies and Optimize Outcomes Webcast (2023)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Upon completion, participants will be familiar with third-line therapies available to treat refractory overactive bladder (OAB), including the pros and cons of each option, the current data regarding outcomes to facilitate proper patient counseling and optimal techniques to maximize the success of the various therapies. The case-based format will provide real-world scenarios by which to learn about the implementation of successful third-line options.
Advances in ADT Part II: A Guide for APPs Webcast (2023)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessment, the AUA has created Advances in ADT: Part II: A Guide for APPs (2023), an educational offering to further update APPs on the latest advancements in androgen deprivation therapy (ADT) and prostate cancer treatment. This educational initiative is comprised of multiple formats, including a live course and on-demand webcast. This live virtual course, which is the cornerstone of the initiative features a multidisciplinary panel, engaging in a lively discussion. 
The Evolving Landscape of Advanced Prostate Cancer Treatment: A Guidelines and Case-Based Discussion Webcast (2023)
    • 4.25 AMA PRA Category 1 Credit™
    • 4.25 Non-Physician Participation
$0.00 As a direct result of the significant increase in multiple FDA-approved therapeutic agents for use in patients with advanced prostate cancer, clinicians are challenged with a multitude of treatment options and potential sequencing of these agents that, consequently, make clinical decision-making more complex. The course will discuss the importance of developing a multidisciplinary approach and key components to establishing a multidisciplinary clinic.
Treatment for Hormone Sensitive Prostate Cancer Webcast (2023)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00
Practice Management & Coding Program Webcast (2022) $1,095.00 Management, Leadership and Coding for Your Urology Practice! This two session webcast combines the AUA’s ever popular Practice Management Conference and annual Coding Seminar into one comprehensive course offering. The purpose of this webcast is to educate physicians and non-physicians alike on the topics impacting the management of today’s urology practice with an increased emphasis on coding and reimbursement. 
Advancing Gender Equity in Urology: Allyship for Men and Advocacy for Women Webcast (2023)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 There is a lack of widespread awareness of how gender bias or sexism affects women in the urological workplace, and while primarily women are contributing to the scientific literature that examines these issues, its dissemination to those in leadership or in charge of policy can be limited. Addressing this requires both advocacy from women and allyship from men to promote fair and equitable work environments.
Building a Primary Palliative Care Model for Urology Webcast (2021)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Building a Primary Palliative Care Model for Urology Webcast (2021) discusses aspects of palliative care that benefit patients, the urologist’s role and their collaboration with palliative care clinicians including:
Managing Toxicities of Checkpoint Inhibitors: A Urologist’s Guide Webcast (2023)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Checkpoint inhibitors (CPIs) are increasingly being utilized in the treatment of urinary tract cancers, with several approvals in metastatic and now nonmetastatic spaces in bladder, kidney and prostate cancer. Urologists are encountering many patients on these therapies and have even started their own infusion programs with immuno -oncology drugs. This course will discuss and provide a structured, case-based approach to managing toxicities from CPIs within a busy urological practice.
Life Long Learning Prep Course Webcast: Module 3: Impotence, Infertility and Andrology (2021) $1,055.00 Specifically designed for anyone unable to get away from the office to attend the Live Course, the Webcast option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials.
Chemotherapy and Immunotherapy for the Urologist and Advanced Practice Provider Webcast (2023)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Review of advanced and metastatic prostate, bladder and kidney cancer. Most recent treatment guidelines are reviewed along with the studies that support them. Different disease spaces in oncologic care are discussed, including the medications used to treat them, their mechanism, side effects and efficacy. Role of the advanced practice provider is discussed for each tumor type. Finally, cases are presented along with management options for audience participationACKNOWLEDGEMENTSIndependent educational grant support provided by:
The Changing Face of Advanced Prostate Cancer Webcast (2023)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 This is an ongoing course on advanced prostate cancer at the AUA Annual Meeting since 2012, and the changes over the last decade have been nothing less than breathtaking! In the early years, it was all about metastatic castrate-resistant prostate cancer (CRPC) with multiple new therapeutic advances starting in 2010, followed by abiraterone and enzalutamide and a focus on bone-targeted agents.
PARPi: Precision Medicine in Advanced Prostate Cancer Webcast (2023)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 The American Urological Association (AUA) has developed a series of live virtual and on-demand educational offerings to further address the identified educational gaps and barriers in advanced prostate cancer care. Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessments, a three-part educational series to update urologists and advanced practice providers (APPs) on PARP-inhibitor (PARPi) treatment in advanced prostate cancer is being offered.

Pages